[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

U.S. Market for Cardiac Ablation & Diagnostic Electrophysiology Devices - (Part of Segment Series)

November 2012 | 91 pages | ID: U1956A9ED90EN
iData Research Inc.

US$ 4,995.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In 2012, the total market for diagnostic EP devices was valued at $408.2 million, an increase over the previous year. The market includes EP stimulator devices, EP catheters and ICE catheters. EP stimulation devices represented only 1.8% of the total diagnostic EP device market, as a relatively small portion as these devices are capital equipment and purchased for Cathlabs. In contrast, EP catheters are used in all EP and cardiac ablation procedures.

In 2012, the cardiac ablation catheter market was valued at $307.1 million, an increase over the previous year. Unit and procedural growth will be the main driver of the market. Over the forecast period, the popularization of more expensive catheter models is expected to mitigate the effects of competitive pricing.

Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for the U.S.

Report Contents:
  • Competitor Analysis
  • Identified Strategic Opportunities
  • Market Overview
  • Trend Analysis
  • Market Drivers & Limiters
  • Mergers & Acquisitions
  • Customer Feedback and Market Monitoring
SubSegments Included:
  • EP Stimulator Devices
  • EP Catheters
  • ICE Catheters
  • RF Ablation Catheter
  • Cryoablation Catheter
Companies Included:
  • St. Jude Medical
  • Boston Scientific
  • Biosense Webster
  • C. R. Bard Electrophysiology
  • Medtronic
  • Micropace
  • Fischer Medical Technologies
  • Arrow International
  • Teleflex
  • SterilMed
Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and secondary research methods.
U.S. MARKET FOR CARDIAC ABLATION & DIAGNOSTIC ELECTROPHYSIOLOGY DEVICES - (PART OF SEGMENT SERIES)

CARDIAC ABLATION MARKET

9.1 INTRODUCTION
9.2 CARDIAC ABLATION PROCEDURES
  9.2.1 Catheter-Based Cardiac Ablation Procedure by Type
9.3 MARKET OVERVIEW
9.4 MARKET ANALYSIS AND FORECAST
  9.4.1 Total RF Ablation Catheter Market
    9.4.1.1 Irrigated RF Ablation Catheter Market
    9.4.1.2 Non-Irrigated RF Ablation Catheter Market
  9.4.2 Cardiac Cryoablation Catheter Market
  9.4.3 Laser Cardiac Ablation Catheter Market
  9.4.4 HIFU Cardiac Ablation System Market
9.5 MARKET DRIVER AND LIMITERS
  9.5.1 RF Ablation Catheter Market
    9.5.1.1 Market Drivers
    9.5.1.2 Market Limiters
  9.5.2 Cardiac Cryoablation Catheter Market
    9.5.2.1 Market Drivers
    9.5.2.2 Market Limiters
9.6 COMPETITIVE ANALYSIS

DIAGNOSTIC ELECTROPHYSIOLOGY DEVICE MARKET

10.1 INTRODUCTION
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
  10.3.1 Total EP Stimulation Device Market
    10.3.1.1 Analog EP Stimulation Device Market
    10.3.1.2 Computerized EP Stimulation Device Market
  10.3.2 Total Diagnostic Electrophysiology Catheter Market
    10.3.2.1 Fixed Curve Diagnostic Electrophysiology Catheter Market
    10.3.2.2 Steerable Diagnostic Electrophysiology Catheter Market
  10.3.3 Intracardiac Echocardiography (ICE) Diagnostic System Market
10.4 MARKET DRIVERS AND LIMITERS
  10.4.1 Market Drivers
  10.4.2 Market Limiters
10.5 COMPETITIVE ANALYSIS


More Publications